Companies in the pharmaceutical and food industries must operate with extreme care to prevent their products from causing more harm than good. One of the most insidious threats these businesses must watch for comes in the form of bacterial endotoxins. These are pieces of bacterial cells that are found on the outer cell membrane of certain microorganisms. Although they are harmless when outside of the body or in the alimentary canal, it is when these endotoxins find their way into the bloodstream that the true danger is revealed.
As pyrogens, endotoxins are known to cause fevers and headaches. In high enough concentrations, however, the effects can be devastating. Lung and kidney failure have been reported, as well as blood clots. In the most severe cases, endotoxins can cause a complete inflammatory response in the body that could eventually lead to septic shock or death.
Protecting Pharmaceutical Production
Preventing outbreaks of illnesses caused by these pathogens is of critical importance to drug manufacturers. Unfortunately, these endotoxins are common in nature. Because of this, they may be found throughout the process of creating pharmaceuticals, which includes everything from the water and raw ingredients to the processing equipment and packaging. Making matters more complicated is the fact that endotoxins cannot be detected by a sterility test.
Both the FDA and USP <797> have set limits on the levels of endotoxins allowed in pharmaceutical products. Each drug has its own acceptable level of these pathogens, which is determined by human tolerance and the route of administration. It is critical for every manufacturer to ensure that they comply with these regulations for a number of reasons. Not only should pharmaceutical companies strive to release the safest drugs possible, but they should also make sure to avoid fines and legal repercussions that may be related to an outbreak of illness.
Technical Safety Services is proud to offer this type of testing alongside our extensive range of solutions for high-purity water systems used in laboratories and manufacturing facilities across the country.
Why Is Endotoxin Testing Important?
Bacterial endotoxin testing is important for ensuring patient safety by detecting toxic, fever-inducing gram-negative bacterial remnants in pharmaceutical products, biologics, and medical devices. These contaminants, which persist after sterilization, can cause severe immune responses, septic shock, or death if they enter the human bloodstream.
Common Sources of Endotoxin Contamination
Endotoxin contamination primarily stems from gram-negative bacteria shedding lipopolysaccharides (LPS) into water, raw materials, and biological components, such as serum. Major sources of endotoxins include insufficiently purified water systems; tubing, plasticware and glassware residue; cell culture additives; animal-derived reagents; heating, ventilation, and air conditioning; and human contamination. These heat-stable toxins persist after sterilization, requiring specific decontamination methods.
Primary Sources of Endotoxin Contamination:
- Water Systems: Purified water, water-for-injection (WFI), and water storage systems are major sources. Gram-negative bacteria can grow in low-nutrient, high-purity water, creating endotoxin-rich biofilms.
- Raw Materials and Supplements: Animal-derived components, particularly Fetal Bovine Serum (FBS), are significant contributors to contamination in cell culture. Other sources include yeast extract, serum, and enzymes.
- Reagents and Additives: Cell culture media, buffers, and additives, such as bovine serum or growth factors, can introduce endotoxin.
- Laboratory Surfaces and Equipment: Contamination can originate from non-sterile pipette tips, glassware, and plasticware, especially if they are not certified pyrogen-free.
- Human Factor: Bacteria present on human skin, hair, and saliva make improper aseptic technique a major source of accidental contamination.
- Manufacturing Environment: Dust, air, and, most importantly, biofilms on equipment and piping can release endotoxins.
Endotoxins can create false positives in pharmaceutical testing primarily via interference from (1,3)-Beta-D-glucans, which trigger the same limulus amebocyte lysate (LAL) clotting enzyme cascade. They compromise materials by binding to drug products or surfaces, leading to low endotoxin recovery (LER). False positives frequently arise from cellulosic filters and raw materials containing glucans.
Common Sources of False Positives:
- (1,3)-Beta-D-glucans: These polysaccharides, found in cellulose filters, fungal products, and some plant materials, mimic endotoxin activity in LAL tests.
- Environmental Contamination: Endotoxins are ubiquitous and often contaminate water or labware, giving a false reading for the material being tested.
- Sample Interference: Components such as proteins or surfactants in the test material can cause non-specific activation of the LAL enzyme, leading to false positives.
- Non-Linearity in Dilutions: When dilutions of a sample do not show a linear reduction in endotoxin concentration, it may indicate that the positive test result is due to interferences such as (1,3)-Beta-D-glucans rather than actual endotoxin.
- Nanomaterial Interference: Nanoparticles can interact directly with LAL reagents, leading to false positives.
Industry Standards & Regulatory Expectations
Endotoxin testing requirements for medical devices and pharmaceutical products are primarily driven by patient safety regulations designed to detect and quantify pyrogens, or fever-causing agents, derived from gram-negative bacteria. The regulations require testing for any product that contacts the cardiovascular system, cerebral spinal fluid, or other sterile tissues. There are several regulatory standards in place that drive endotoxin testing methods in pharmaceuticals and medical devices.
Key Regulatory Standards:
- USP Chapter <85> (Bacterial Endotoxins Test): The foundational U.S. standard, harmonized with European and Japanese pharmacopoeias. In this test, the sample is added to a test tube containing LAL, which will either coagulate and form a clot in the presence of endotoxins, or will run freely down the sides of the test tube when turned upside down if no endotoxins are present.
- USP Chapter <86> (Bacterial Endotoxins Test): Recombinant Reagents: Covers modern alternatives like recombinant Factor C (rFC) or recombinant Cascade Reagents (rCR).
- USP Chapter <161> (Medical Devices): Defines limits specifically for medical devices. For most devices the limit is <20.0 USP Endotoxin Units per device.
- ANSI/AAMI ST72:2019: Provides guidelines for testing methodologies, such as gel clot, kinetic chromogenic, and kinetic turbidimetric tests; routine monitoring; and alternatives to batch testing.
- FDA Guidance: Requires testing to ensure devices are free from harmful levels of endotoxins and requires manufacturers to comply with USP <85> Bacterial Endotoxins Test for drug products and USP <161> for medical devices to ensure safety.
- ISO 11737-3:2023: Covers methods for quantifying endotoxins in/on healthcare products using
USP <85> Bacterial Endotoxins Test methods.
Rigorous endotoxin testing is important as recalls, manufacturing delays, patient safety and liability can result from endotoxin detection. Endotoxins can cause severe fever, septic shock, organ failure, or death if they enter the bloodstream.
Interpretation of Endotoxin Test Results
Endotoxin Units per milliliter (EU/mL), are interpreted based on strict regulatory thresholds to prevent pyrogenic reactions. General standards require levels below 0.5 EU/mL for most parenteral drugs and
0.25–0.5 EU/mL for devices, while intrathecal products must be below 0.06 EU/mL, using LAL testing.
Bacterial endotoxin test results (LAL test) are interpreted by comparing sample endotoxin levels against established limits, ensuring system suitability controls are valid. A sample complies if endotoxin concentration is below the limit, typically EU/kg in humans, validated by a 50%-200% spike recovery in quantitative methods.
When endotoxin limits are exceeded in pharmaceutical or medical device manufacturing, immediate corrective actions are triggered to ensure patient safety and identify the source of contamination. Generally, the affected batch, and all intermediate materials, are immediately quarantined. An investigation is initiated to determine the cause. Re-testing is conducted to determine the source. If the results confirm endotoxin limits are exceeded the batch is rejected.
Best Practices for Minimizing Contamination Risk
To minimize endotoxin contamination requires a proactive approach centered on using endotoxin-free materials. Rigorous water purification is important. Using certified endotoxin-free, or pyrogen-free water, buffers, and regents is critical. Selecting certified non-pyrogenic disposable plasticware is highly advisable. Raw materials and components must be sourced from suppliers with strict endotoxin specifications. Regularly test water systems with Bacterial Endotoxin Testing using LAL assays is highly recommended.
Effective depyrogenation of tubing, glassware, and equipment at 480°F or 250°C for 30 minutes is required.
This will effectively destroy endotoxins. Use validated cleaning agents and disinfectants separately. Use specialized, high-retention wipes to physically remove submicron cell debris. Flush tubing and instruments with sodium hydroxide (NaOH) or specialized detergent cleaners, followed by rinsing with certified endotoxin-free water. Use validation steps to confirm that cleaning processes effectively reduce endotoxin levels.
Implementing rigorous aseptic techniques is also critical. Personnel should gown, wearing masks, hairnets, and use frequent glove changes to prevent contamination from skin or breath. Educate personnel on the importance of limiting movement in cleanrooms and maintaining sterile barriers.
Why Technical Safety Services is Your Go-To Source
Companies across multiple industries turn to Technical Safety Services for our expertise when it comes to testing and certification of cleanrooms and other controlled environments. We stand apart as one of the leaders in this space thanks in no small part to the depth of our expertise and the comprehensive lineup of services we provide.
In everything we do, we strive to give our clients a commitment to the absolute highest standards of quality and strict protocols. We have the experience and capabilities needed to ensure companies that require the strictest levels of purity have everything they need. To learn more about our services, get in touch with us and find out what we can do for you.
